The CDKL5 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-mediated gene-disrupted polyclonal cell population derived from the human Raji B lymphoblastoid line. This model provides a loss-of-function system for the CDKL5 gene, enabling investigation of CDKL5-dependent signaling in a lymphoid cellular context. The polyclonal format incorporates a heterogeneous pool of edited alleles, reducing clonal selection artifacts and enhancing the robustness of phenotypic observations.
The Raji cell line is an Epstein-Barr virus-positive B lymphoblastoid line established from a Burkitt lymphoma. Raji cells proliferate in suspension and express characteristic B-cell markers, making them a widely employed model in immunological studies, cancer biology, and host-pathogen interactions. The EBV-immortalized background offers a relevant system to explore non-canonical functions of CDKL5 beyond its established roles in neuronal development.
CDKL5 encodes a serine/threonine protein kinase that phosphorylates key substrates including MECP2, DLG4/PSD-95, and LRRC4/NGL-1, thereby regulating dendritic arborization, synaptic plasticity, and gene expression. CDKL5 activity is modulated by calcium signaling, neuronal activity, and mitogenic stimuli, and it interacts with importin alpha and CAMK2A. Downstream, CDKL5-mediated phosphorylation of MECP2 influences its DNA binding and HDAC4 recruitment, while DLG4 phosphorylation affects synaptic scaffolding. The kinase also feeds into the Akt/mTOR pathway, impacting cell proliferation and survival.
In Raji B lymphoblasts, CDKL5 knockout likely disrupts phosphorylation-dependent signaling cascades that intersect with Akt/mTOR-mediated proliferation and survival pathways. This model permits the dissection of CDKL5??s role in lymphocyte biology, including cell cycle progression and apoptosis, while providing a platform for drug screening to identify compounds that compensate for CDKL5 deficiency. The polyclonal design ensures that diverse editing events are represented, minimizing clonal bias and facilitating robust functional studies.
Typical research applications include Western blotting and RT-qPCR for knockout validation, immunofluorescence for subcellular localization, flow cytometry for apoptosis and cell cycle profiling, and phospho-protein analysis of p-MECP2 and p-AKT. MTT cell proliferation assays provide quantitative growth readouts. These cells are valuable for investigations into CDKL5 deficiency disorder, atypical Rett syndrome, and other neurodevelopmental conditions, as well as for cancer signaling studies in B-cell malignancies. For further information or to discuss custom applications, please contact Ascent Research.
